Literature DB >> 20583761

One concept, three implementations of 3D pharmacophore-based virtual screening: distinct coverage of chemical search space.

Gudrun M Spitzer1, Mathias Heiss, Martina Mangold, Patrick Markt, Johannes Kirchmair, Gerhard Wolber, Klaus R Liedl.   

Abstract

Feature-based pharmacophore modeling is a well-established concept to support early stage drug discovery, where large virtual databases are filtered for potential drug candidates. The concept is implemented in popular molecular modeling software, including Catalyst, Phase, and MOE. With these software tools we performed a comparative virtual screening campaign on HSP90 and FXIa, taken from the 'maximum unbiased validation' data set. Despite the straightforward concept that pharmacophores are based on, we observed an unexpectedly high degree of variation among the hit lists obtained. By harmonizing the pharmacophore feature definitions of the investigated approaches, the exclusion volume sphere settings, and the screening parameters, we have derived a rationale for the observed differences, providing insight on the strengths and weaknesses of these algorithms. Application of more than one of these software tools in parallel will result in a widened coverage of chemical space. This is not only rooted in the dissimilarity of feature definitions but also in different algorithmic search strategies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20583761     DOI: 10.1021/ci100136b

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  12 in total

1.  A combined molecular modeling study on a series of pyrazole/isoxazole based human Hsp90α inhibitors.

Authors:  Ying Yang; Huanxiang Liu; Juan Du; Jin Qin; Xiaojun Yao
Journal:  J Mol Model       Date:  2011-03-04       Impact factor: 1.810

2.  De novo design by pharmacophore-based searches in fragment spaces.

Authors:  Tobias Lippert; Tanja Schulz-Gasch; Olivier Roche; Wolfgang Guba; Matthias Rarey
Journal:  J Comput Aided Mol Des       Date:  2011-09-16       Impact factor: 3.686

Review 3.  In Silico Studies in Drug Research Against Neurodegenerative Diseases.

Authors:  Farahnaz Rezaei Makhouri; Jahan B Ghasemi
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

4.  Pharmer: efficient and exact pharmacophore search.

Authors:  David Ryan Koes; Carlos J Camacho
Journal:  J Chem Inf Model       Date:  2011-06-02       Impact factor: 4.956

5.  5-HT1A receptor pharmacophores to screen for off-target activity of α1-adrenoceptor antagonists.

Authors:  Tony Ngo; Timothy J Nicholas; Junli Chen; Angela M Finch; Renate Griffith
Journal:  J Comput Aided Mol Des       Date:  2013-04-27       Impact factor: 3.686

6.  ZINCPharmer: pharmacophore search of the ZINC database.

Authors:  David Ryan Koes; Carlos J Camacho
Journal:  Nucleic Acids Res       Date:  2012-05-02       Impact factor: 16.971

7.  Discriminating agonist and antagonist ligands of the nuclear receptors using 3D-pharmacophores.

Authors:  Nathalie Lagarde; Solenne Delahaye; Jean-François Zagury; Matthieu Montes
Journal:  J Cheminform       Date:  2016-09-06       Impact factor: 5.514

8.  Spectrophores as one-dimensional descriptors calculated from three-dimensional atomic properties: applications ranging from scaffold hopping to multi-target virtual screening.

Authors:  Rafaela Gladysz; Fabio Mendes Dos Santos; Wilfried Langenaeker; Gert Thijs; Koen Augustyns; Hans De Winter
Journal:  J Cheminform       Date:  2018-03-07       Impact factor: 5.514

Review 9.  Drug Design for CNS Diseases: Polypharmacological Profiling of Compounds Using Cheminformatic, 3D-QSAR and Virtual Screening Methodologies.

Authors:  Katarina Nikolic; Lazaros Mavridis; Teodora Djikic; Jelica Vucicevic; Danica Agbaba; Kemal Yelekci; John B O Mitchell
Journal:  Front Neurosci       Date:  2016-06-10       Impact factor: 4.677

10.  Truly Target-Focused Pharmacophore Modeling: A Novel Tool for Mapping Intermolecular Surfaces.

Authors:  Jérémie Mortier; Pratik Dhakal; Andrea Volkamer
Journal:  Molecules       Date:  2018-08-06       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.